The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future.

MLA

Godman, Brian, et al. “The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future.” Frontiers in Public Health, vol. 9, June 2021, p. 671961. EBSCOhost, https://doi.org/10.3389/fpubh.2021.671961.

APA

Godman, B., Haque, M., Leong, T., Allocati, E., Kumar, S., Islam, S., Charan, J., Akter, F., Kurdi, A., Vassalo, C., Bakar, M. A., Rahim, S. A., Sultana, N., Deeba, F., Khan, M. A. H., Alam, A. B. M. M., Jahan, I., Kamal, Z. M., Hasin, H., … Jakovljevic, M. (2021). The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future. Frontiers in Public Health, 9, 671961. https://doi.org/10.3389/fpubh.2021.671961

Chicago

Godman, Brian, Mainul Haque, Trudy Leong, Eleonora Allocati, Santosh Kumar, Salequl Islam, Jaykaran Charan, et al. 2021. “The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future.” Frontiers in Public Health 9 (June): 671961. doi:10.3389/fpubh.2021.671961.